Suppression of human hepatoma (HepG2) cell growth by nuclear factor-kappaB/p65 specific siRNA

Tumor Biology

Volumn 31, Issue 6, 2010, Pages 605-611

  Wu, Wei ^a   Yao, Dengfu ^a   Wang, Yilang ^a,b   Qiu, Liwei ^a   Sai, Wenli ^a   Yang, Junling ^a   Yao, Ninghua ^a   Li, Shanshan ^a   Bian, Yinzhu ^a   Wang, Zhiwei ^a   Yao, Dengbing ^a  

^a NANTONG UNIVERSITY   (China)

^b Nantong First People's Hospital   (China)

Author keywords

Apoptosis; Gene therapy; Hepatocellular carcinoma; Nuclear factor kappaB; Real time PCR; Small interference RNA

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 78449241069     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-010-0076-y     Document Type: Article

References (36)

1. RN Aravalli CJ Steer EN Cressman 2008 Molecular mechanisms of hepatocellular carcinoma Hepatology 48 2047 2063 10.1002/hep.22580 19003900 1:CAS:528:DC%2BD1cXhsFams7%2FM [PMID:19003900]
2. DF Yao ZZ Dong M Yao 2007 Specific molecular markers in hepatocellular carcinoma Hepatobiliary Pancreat Dis Int 6 3 241 247 17548245 1:CAS:528:DC%2BD2sXns1KgtLc%3D [PMID: 17548245]
3. M Frau F Biasi F Feo RM Pascale 2010 Prognostic markers and putative therapeutic targets for hepatocellular carcinoma Mol Aspects Med 31 2 179 193 10.1016/j.mam.2010.02.007 20176048 1:CAS:528:DC%2BC3cXksFGqurc%3D [PMID: 20176048]
4. F Feo M Frau ML Tomasi S Brozzetti RM Pascale 2009 Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma Exp Biol Med (Maywood) 234 7 726 736 10.3181/0901-MR-40 1:CAS:528:DC%2BD1MXotlWrtLo%3D [PMID: 19429855]
5. ZZ Dong DF Yao W Wu M Yao HB Yu JJ Shen, et al. 2010 Delayed hepatocarcinogenesis through antiangiogenic intervention in the nuclear factor-kappa B activation pathway in rats Hepatobiliary Pancreat Dis Int 9 2 169 174 20382589 1:CAS:528:DC%2BC3cXlvFOltrs%3D [PMID: 20382589]
6. Y He H Zhang J Yin J Xie X Tan S Liu, et al. 2009 IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C Carcinogenesis 30 11 1916 1922 10.1093/carcin/bgp226 19797428 1:CAS:528:DC%2BD1MXhsV2jtb3M [PMID: 19797428]
7. R Jiang Y Xia J Li L Deng L Zhao J Shi, et al. 2010 High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer Int J Cancer 126 5 1263 1274 19728335 1:CAS:528:DC%2BC3cXjsFem [PMID: 19728335]
8. C Berasain J Castillo MJ Perugorria MU Latasa J Prieto MA Avila 2009 Inflammation and liver cancer: new molecular links Ann NY Acad Sci 1155 206 221 10.1111/j.1749-6632.2009.03704.x 19250206 1:CAS:528:DC%2BD1MXktFKltrk%3D [PMID: 19250206]
9. KK Auyeung PC Law JK Ko 2009 Astragalus saponins induce apoptosis via an ERK-independent NF-kappaB signaling pathway in the human hepatocellular HepG2 cell line Int J Mol Med 23 2 189 196 19148542 1:CAS:528:DC%2BD1MXisVGit7o%3D [PMID: 19148542]
10. LP Liu HF Liang XP Chen WG Zhang SL Yang T Xu, et al. 2010 The role of NF-kappaB in Hepatitis b virus X protein-mediated upregulation of VEGF and MMPs Cancer Investig 28 5 443 451 10.3109/07357900903405959 1:CAS:528: DC%2BC3cXlslClu7k%3D [PMID: 20073580]
11. HR Kim SH Lee G Jung 2010 The hepatitis B viral X protein activates NF-kappaB signaling pathway through the up-regulation of TBK1 FEBS Lett 584 3 525 530 10.1016/j.febslet.2009.11.091 19958770 1:CAS:528:DC%2BC3cXhtVGns7w%3D [PMID: 19958770]
12. GW Vainer E Pikarsky Y Ben-Neriah 2008 Contradictory functions of NF-kappaB in liver physiology and cancer Cancer Lett 267 2 182 188 10.1016/j.canlet.2008.03.016 18479806 1:CAS:528:DC%2BD1cXovF2hsLo%3D [PMID: 18479806]
13. DF Calvisi RM Pascale F Feo 2007 Dissection of signal transduction pathways as a tool for the development of targeted therapies of hepatocellular carcinoma Rev Recent Clin Trials 2 3 217 236 10.2174/157488707781662715 18474008 1:CAS:528:DC%2BD2sXhtFGqtbjO [PMID: 18474008]
14. BH O'Neil P Bůzková H Farrah D Kashatus H Sanoff RM Goldberg, et al. 2007 Expression of nuclear factor-kappaB family proteins in hepatocellular carcinomas Oncology 72 1-2 97 104 10.1159/000111116 18025803 1:CAS:528:DC%2BD2sXhtlyksLrL [PMID: 18025803]
15. L Guo Y Guo S Xiao 2007 Expression of tyrosine kinase Etk/Bmx and its relationship with AP-1- and NF-kappaB-associated proteins in hepatocellular carcinoma Oncology 72 5-6 410 416 10.1159/000113491 18196928 1:CAS:528:DC%2BD1cXhs1yitLw%3D [PMID: 18196928]
16. K Guo NX Kang Y Li L Sun L Gan FJ Cui MD Gao KY Liu 2009 Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis BMC Cancer 9 100 10.1186/1471-2407-9- 100 19331697 1:CAS:528:DC%2BD1MXltFGnu7o%3D [PMID: 19331697]
17. JM Wu H Sheng R Saxena NJ Skill P Bhat-Nakshatri M Yu, et al. 2009 NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy Cancer Lett 278 2 145 155 10.1016/j.canlet.2008.12.031 19303700 1:CAS:528:DC%2BD1MXltVCqsrw%3D [PMID: 19303700]
18. F Wang S Kaur LG Cavin M Arsura 2008 Nuclear-factor-kappaB (NF-kappaB) and radical oxygen species play contrary roles in transforming growth factor-beta1 (TGF-beta1)-induced apoptosis in hepatocellular carcinoma (HCC) cells Biochem Biophys Res Commun 377 4 1107 1112 10.1016/j.bbrc.2008.10.130 18983820 1:CAS:528:DC%2BD1cXhsVGhu73M [PMID: 18983820]
19. SG Park JY Min C Chung A Hsieh G Jung 2009 Tumor suppressor protein p53 induces degradation of the oncogenic protein HBx Cancer Lett 282 2 229 237 10.1016/j.canlet.2009.03.019 19375220 1:CAS:528:DC%2BD1MXosVaisrk%3D [PMID: 19375220]
20. Y Sato J Kato R Takimoto K Takada Y Kawano K Miyanishi, et al. 2006 Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB Gut 55 12 1801 1808 10.1136/gut.2005.070417 16581947 1:CAS:528:DC%2BD2sXkvFOjug%3D%3D [PMID: 16581947]
21. W Wu DF Yao LW Qiu WL Sai JJ Shen HB Yu, et al. 2009 Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis Hepatobiliary Pancreat Dis Int 8 5 504 509 19822494 1:CAS:528:DC%2BD1MXhtl2ksLrE [PMID: 19822494]
22. LH Butterfield 2007 Recent advances in immunotherapy for hepatocellular cancer Swiss Med Wkly 137 83 90 17370144 1:CAS:528:DC%2BD2sXjsF2ks7Y%3D [PMID: 17370144]
23. JM Llovet J Bruix 2008 Molecular targeted therapies in hepatocellular carcinoma Hepatology 48 1312 1317 10.1002/hep.22506 18821591 1:CAS:528:DC%2BD1cXht1Khu7zP [PMID:18821591]
24. CS Chang SM Huang HH Lin CC Wu CJ Wang 2007 Different expression of apoptotic proteins between HBV-infected and non-HBV-infected hepatocellular carcinoma Hepatogastroenterology 54 79 2061 2068 18251160 1:CAS:528: DC%2BD1cXpvVWqsg%3D%3D [PMID: 18251160]
25. M Nasimuzzaman G Waris D Mikolon DG Stupack A Siddiqui 2007 Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor J Virol 81 19 10249 10257 10.1128/JVI.00763-07 17626077 1:CAS:528:DC%2BD2sXhtV2gtbrN [PMID: 17626077]
26. K Yoneda K Sugimoto K Shiraki J Tanaka T Beppu H Fuke, et al. 2008 Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis Int J Oncol 33 5 929 936 18949355 1:CAS:528: DC%2BD1cXhsVaiu7%2FN [PMID: 18949355]
27. KF Chen PY Yeh KH Yeh YS Lu SY Huang AL Cheng 2008 Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells Cancer Res 68 16 6698 6707 10.1158/0008-5472.CAN- 08-0257 18701494 1:CAS:528:DC%2BD1cXpslKmsL8%3D [PMID: 18701494]
28. R Cheong A Hoffmann A Levchenko 2008 Understanding NF-kappaB signaling via mathematical modeling Mol Syst Biol 4 192 202 10.1038/msb.2008.30 18463616 [PMID: 18463616]
29. S Maeda M Omata 2008 Inflammation and cancer: role of nuclear factor-kappaB activation Cancer Sci 99 836 842 10.1111/j.1349-7006.2008.00763.x 18294278 1:CAS:528:DC%2BD1cXlslCrsLk%3D [PMID: 18294278]
30. AM Elsharkawy DA Mann 2007 Nuclear factor-kappaB and the hepatic inflammation- fibrosis-cancer axis Hepatology 46 590 597 10.1002/hep.21802 17661407 1:CAS:528:DC%2BD2sXhtVSisbzF [PMID: 17661407]
31. C Van Waes 2007 Nuclear factor-kappaB in development, prevention, and therapy of cancer Clin Cancer Res 13 1076 1082 10.1158/1078-0432.CCR-06-2221 17317814 [PMID: 17317814]
32. SW Ding O Voinnet 2007 Antiviral immunity directed by small RNAs Cell 130 413 426 10.1016/j.cell.2007.07.039 17693253 1:CAS:528:DC%2BD2sXptlyntLY%3D [PMID: 17693253]
33. X Song JB Wang DL Yin HY Yang LX Liu HC Jiang 2009 Down-regulation of lung resistance related protein by RNA interference targeting survivin induces the reversal of chemoresistances in hepatocellular carcinoma Chin Med J (Engl) 122 21 2636 2642 1:CAS:528:DC%2BD1MXhsFenu7nJ [PMID: 19951584]
34. A Sharma AK Upadhyay MK Bhat 2009 Inhibition of Hsp27 and Hsp40 potentiates 5-fluorouracil and carboplatin mediated cell killing in hepatoma cells Cancer Biol Ther 8 22 2106 2113 19901540 1:CAS:528:DC%2BC3cXpt1Squ7g%3D [PMID: 19901540]
35. K Kohga T Takehara T Tatsumi T Miyagi H Ishida K Ohkawa, et al. 2009 Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma Cancer Res 69 20 8050 8057 10.1158/0008-5472.CAN-09-0789 19826051 1:CAS:528:DC%2BD1MXht1ynurfI [PMID: 19826051]
36. J Wang T Tokoro S Higa I Kitajima 2006 Anti-inflammatory effect of pitavastatin on NF-kappaB activated by TNF-alpha in hepatocellular carcinoma cells Biol Pharm Bull 29 4 634 639 10.1248/bpb.29.634 16595893 1:CAS:528:DC%2BD28XkslOis78%3D [PMID: 16595893]